BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, June 21, 2026
Home » Authors » Douglas Merrill

Articles by Douglas Merrill

German BioChance Program Funds Six Start-Up Companies

June 19, 2002
By Douglas Merrill
MUNICH, Germany - The German Ministry of Education and Research is supporting six new biotech companies with grants of approximately €1 million (US$950,000) each. The investment is part of the BioChance program, which has delivered more than €50 million to 52 biotech start-ups since the program's start in 1999. (BioWorld International)
Read More

Merck Chief Considers Building In U.S. Rather Than Germany

June 19, 2002
By Douglas Merrill

Curacyte, VitaResc Merging As Part Of German Consolidation

June 12, 2002
By Douglas Merrill

Curacyte, VitaResc Merging As Part Of German Consolidation

June 12, 2002
By Douglas Merrill

Wilex, German Universities Start Phase III To Assess uPA's Utility

June 5, 2002
By Douglas Merrill

Wilex, German Universities Start Phase III To Assess uPA's Utility

June 5, 2002
By Douglas Merrill

Atugen, Byk Gulden Collaborate On Validation Of Genetic Targets

May 29, 2002
By Douglas Merrill

Atugen, Byk Gulden Collaborate On Validation Of Genetic Targets

May 29, 2002
By Douglas Merrill

Government Details Growth Of German Biotechnology Industry

May 15, 2002
By Douglas Merrill
MUNICH, Germany - Presenting the German government's annual report on the biotechnology sector's development, Edelgard Bulman, federal minister for research, said the number of biotech companies in Germany rose from 332 to 365 in 2001. (BioWorld International)
Read More

Government Details Growth Of German Biotechnology Industry

May 15, 2002
By Douglas Merrill
MUNICH, Germany - Presenting the German government's annual report on the biotechnology sector's development, Edelgard Bulman, federal minister for research, said the number of biotech companies in Germany rose from 332 to 365 in 2001. (BioWorld International)
Read More
Previous 1 2 … 19 20 21 22 23 24 25 26 27 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 18, 2026.
  • Wireframe of feet and scale

    GLP-1s need technologies for long-term use

    BioWorld
    For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
  • UTRN gene involved in arthrogryposis, study finds

    BioWorld Science
    Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
  • Blue-gray dollar sign

    HMNC raises $50M series B to prep depression drugs for phase III

    BioWorld
    HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
  • Illustration of glucose in the blood stream

    CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research

    BioWorld Science
    Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing